Ledaborbactam etzadroxil clinical trials
Also written VNRX-7145.
How each study uses ledaborbactam etzadroxil is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the ledaborbactam etzadroxil studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
5 studies that test it; most in 2022 (2)
| Year | Studies |
|---|---|
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 5
Who runs them
Industry 5 · Other 0
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
- One of Beta-lactamase inhibitors source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test ledaborbactam etzadroxil.
- Dec 2026Safety and PK of Ceftibuten-ledaborbactam Etzadroxil Fixed-dose CombinationPhase 1 · Basilea Pharmaceutica
Studies
Open first, then newest update. How each study uses ledaborbactam etzadroxil is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- Safety and PK of Ceftibuten-ledaborbactam Etzadroxil Fixed-dose CombinationRecruitingPhase 1Basilea PharmaceuticaNCT06733675Written as Ledaborbactam etzadroxil
- Food Effect on Ceftibuten/VNRX-7145 in Healthy ParticipantsCompletedPhase 1Basilea PharmaceuticaNCT05527834Written as VNRX-7145
- VNRX-7145 Drug-Drug Interaction in Healthy Adult VolunteersCompletedPhase 1Basilea PharmaceuticaNCT04877379Written as VNRX-7145
- Ceftibuten/VNRX-7145 in Participants With Varying Degrees of Renal FunctionCompletedPhase 1Basilea PharmaceuticaNCT05488678Written as VNRX-7145
- VNRX-7145 SAD/MAD Safety and PK in Healthy Adult VolunteersCompletedPhase 1Basilea PharmaceuticaNCT04243863Written as VNRX-7145
Given beside what is tested · 1 — ledaborbactam etzadroxil is usual care or a partner of the new treatment
Codes
What other systems call ledaborbactam etzadroxil · ClinicalTrials.gg INT016185
- UNII (FDA) C5F376EKS2LEDABORBACTAM ETZADROXILOne source FDA
- NCI Thesaurus C184847Ledaborbactam EtzadroxilOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | C5F376EKS2 | LEDABORBACTAM ETZADROXIL | One source FDA |
| NCI Thesaurus | C184847 | Ledaborbactam Etzadroxil | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.